Recently, Chakraborty et al. showed that biallelic loss of TP53/CDKN2A/2B induced BCR-dependent proliferation of CLL cells and transformation into an aggressive RS-like phenotype in vivo and in vitro [18]. Here, TP53 is linked to B-cell chronic lymphocytic leukemia.